Christopher Baum
Impact in
- Neurology top 2%
- Neuroinflammation and Neurodegeneration Mechanisms
- Biological Psychiatry top 5%
Papers in
-
- RNA Interference and Gene Delivery 21
- CRISPR and Genetic Engineering 20
- Pluripotent Stem Cells Research 5
- Viral Infectious Diseases and Gene Expression in Insects 3
- Genetics 36
- Virus-based gene therapy research 34
- Animal Genetics and Reproduction 4
- Co-authors
- Axel Schambach (23 shared papers)Boris Fehse (7 shared papers)Matthias Eder (3 shared papers)Cornelia Zeidler (2 shared papers)Michaela Scherr (2 shared papers)Murat Uenalan (2 shared papers)Manuela Germeshausen (2 shared papers)Rudolf Grosschedl (2 shared papers)
- Journals
- Blood (7 papers)Human Gene Therapy (7 papers)Molecular Therapy (6 papers)Current Gene Therapy (3 papers)Nature Medicine (3 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Christopher Baum
48 papers receiving 3.7k citations
Christopher Baum's Hit Papers
Peers
Comparison fields: 5 of 112
- Neurology 463
- Biological Psychiatry 133
- Genetics 1.5k
- Molecular Biology 2.2k
- Virology 127
Countries citing papers authored by Christopher Baum
This map shows the geographic impact of Christopher Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Baum more than expected).
Fields of papers citing papers by Christopher Baum
This network shows the impact of papers produced by Christopher Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Baum. The network helps show where Christopher Baum may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Baum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia Hit paper breakdown → | 2006 | 1005 |
| 2 | Murine Leukemia Induced by Retroviral Gene Marking Hit paper breakdown → | 2002 | 533 |
| 3 | 2009 | 308 | |
| 4 | 2006 | 168 | |
| 5 | 2005 | 167 | |
| 6 | 2003 | 143 | |
| 7 | 2010 | 118 | |
| 8 | 2011 | 112 | |
| 9 | 1998 | 96 | |
| 10 | 2012 | 92 | |
| 11 | 2010 | 77 | |
| 12 | 2012 | 71 | |
| 13 | 2008 | 67 | |
| 14 | 2012 | 62 | |
| 15 | 2010 | 60 | |
| 16 | 1994 | 57 | |
| 17 | 2011 | 56 | |
| 18 | 1998 | 48 | |
| 19 | 2008 | 44 | |
| 20 | 1999 | 43 |
About Christopher Baum
Christopher Baum is a scholar working on Molecular Biology, Genetics, Oncology, Immunology and Epidemiology, having authored 49 papers that have together received 3.7k indexed citations. Recurring topics across this work include Virus-based gene therapy research (34 papers), RNA Interference and Gene Delivery (21 papers), CRISPR and Genetic Engineering (20 papers), CAR-T cell therapy research (7 papers), Pluripotent Stem Cells Research (5 papers), Animal Genetics and Reproduction (4 papers), Immune Cell Function and Interaction (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). The work is most often cited by research in Neurology (463 citations), Biological Psychiatry (133 citations), Genetics (1.5k citations), Molecular Biology (2.2k citations) and Virology (127 citations). Christopher Baum has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Axel Schambach, Boris Fehse, Matthias Eder, Cornelia Zeidler, Michaela Scherr, Murat Uenalan, Manuela Germeshausen, Rudolf Grosschedl, Martin Stanulla and Karl Welte. Their work appears in journals such as Blood, Human Gene Therapy, Molecular Therapy, Current Gene Therapy and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.